🔼 We saw an infographic showing that the #Injective ecosystem currently ranks second in terms of capital inflow and retention. (First place goes to #Ethereum 
ETH with a threefold lead.)
🕯 Now let's check this information on the
INJUSDT price chart, and we can see that there is indeed “buyer power”. After two months of growth, the price of #INJUSD is now adjusting quite moderately.
🍿 So, if #Injective is “preparing something really interesting” for the summer, then the price of their #INJ token should not fall below $10.
From there, it will be possible to organize “modest” growth, at least up to $27.
_____________________
Did you like our analysis? Leave a comment, like, and follow to get more
ETH with a threefold lead.)🕯 Now let's check this information on the
INJUSDT price chart, and we can see that there is indeed “buyer power”. After two months of growth, the price of #INJUSD is now adjusting quite moderately.🍿 So, if #Injective is “preparing something really interesting” for the summer, then the price of their #INJ token should not fall below $10.
From there, it will be possible to organize “modest” growth, at least up to $27.
_____________________
Did you like our analysis? Leave a comment, like, and follow to get more
🎁 -20% on ALL trading fees OKX
okx.com/join/20PSTRADE
🔥V-I-P cutt.ly/PwkLhT56
👍Daily bitcoin reviews here💲 cutt.ly/3wnaaG4s
🔵Telegram t.me/pstrade_eng
okx.com/join/20PSTRADE
🔥V-I-P cutt.ly/PwkLhT56
👍Daily bitcoin reviews here💲 cutt.ly/3wnaaG4s
🔵Telegram t.me/pstrade_eng
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🎁 -20% on ALL trading fees OKX
okx.com/join/20PSTRADE
🔥V-I-P cutt.ly/PwkLhT56
👍Daily bitcoin reviews here💲 cutt.ly/3wnaaG4s
🔵Telegram t.me/pstrade_eng
okx.com/join/20PSTRADE
🔥V-I-P cutt.ly/PwkLhT56
👍Daily bitcoin reviews here💲 cutt.ly/3wnaaG4s
🔵Telegram t.me/pstrade_eng
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.